No shortage on file

SODIUM ACETATE INJECTION USP

OMEGA LABORATORIES LIMITED

Quick answers

Is there a shortage of SODIUM ACETATE INJECTION USP in Canada?

No. There is no current shortage of SODIUM ACETATE INJECTION USP 328MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on fileNone found

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

Sodium Acetate Injection USP

Sodium Acetate Injection USP; Incorrect GTIN

Type II2025-03-05

Moderate health risk

Possible match — not confirmed

Sodium Acetate Injection, USP

Sodium Acetate Injection, USP - Potential for the Presence of Particulate Matter

2022-03-15

Possible match — not confirmed

Sodium Acetate Injection, USP

Sodium Acetate Injection, USP: Particulate matter

Type I2022-03-07

Highest health risk

Possible match — not confirmed

DIN

02181746

Strength

328MG

Dosage Form

Solution

Route

Intravenous

Active Ingredient

SODIUM ACETATE

See all SODIUM ACETATE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

No shortage or discontinuation reports on file for this product.

Other Products from OMEGA LABORATORIES LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION USP

9MG · DIN 02150204

AMIKACIN SULFATE INJECTION

250MG · DIN 02486717

AMINOPHYLLINE INJ 25MG/ML

25MG · DIN 00582662

AMINOPHYLLINE INJ 50MG/ML

50MG · DIN 00582654

BAXEDIN 2% - 70%

DIN 02251477

BAXEDIN LIQ 20%

20% · DIN 00658413